Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2459-2467

  Bardou, Fabienne ^a   Quémard, Annaïk ^a   Dupont, Marie Ange ^b   Horn, Cynthia ^c   Marchal, Gilles ^c   Daffé, Mamadou ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CNRS   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ISONIAZID; MYCOLIC ACID;

ARTICLE; BACTERIAL MEMBRANE; BACTERIOSTASIS; CELL ULTRASTRUCTURE; DRUG EFFECT; ELECTRON MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0029911052     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2459     Document Type: Article

References (33)

1. Andersen, A. B., and P. J. Brennan. 1994. Proteins and antigens of Mycobacterium tubercolosis, p. 307-332. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
2. Andersen, A. B., L. Ljungqvist, K. Haslov, and M. W. Bentzon. 1991. MPB 64 possesses 'tuberculosis-complex'-specific B- and T-cell epitopes. Scand. J. Immunol. 34:365-372.
3. Andersen, A. B., Z. L. Yuan, K. Haslov, B. Vergmann, and J. Bennedsen. 1986. Interspecies reactivity of five monoclonal antibodies to Mycobacterium tuberculosis as examined by immunoblotting and enzyme-linked immunosorbent assay. J. Clin. Microbiol. 23:446-451.
4. Banerjee, A., E. Dubnau, A. Quémard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
5. Daffé, M., M. A. Dupont, and N. Gas. 1989. The cell envelope of Mycobacterium smegmatis: cytochemistry and architectural implications. FEMS Microbiol. Lett. 51:89-94.
6. Daffé, M., M. A. Lanéelle, C. Asselineau, V. Lévy-Frébault, and H. L. David. 1983. Intérêt taxonomique des acides gras des mycobactéries: proposition d'une méthode d'analyse. Ann. Microbiol. (Inst. Pasteur) 134B:241-256.
7. Dessen, A., A. Quémard, J. S. Blanchard, W. R. Jacobs, and J. C. Sacchettini. 1995. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267:1638-1641.
8. Dische, Z. 1962. Color reaction of hexoses. Methods Carbohydr. Chem. 1:488-494.
9. Lapchine, L., and C. Asselineau. 1981. Présence d'un bactériophage chez Mycobacierium phlei. Ann. Microbiol. (Inst. Pasteur) 132A:129-139.
10. Laqueyrerie, A., P. Militzer, F. Romain, K. Eiglmeier, S. Cole, and G. Marchal. 1995. Cloning, sequencing, and expression of the apa gene coding for the Mycobacierium tuberculosis 45/47-kilodalton secreted antigen complex. Infect. Immun. 63:4003-4010.
11. Lemassu, A., and M. Daffé. 1994. Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem. J. 297:351-357.
12. Lemassu, A., A. Ortalo-Magné, F. Bardou, G. Silve, M. A. Lanéelle, and M. Daffé. 1996. Extracellular and surface-exposed polysaccharides of non tuberculous mycobacteria. Microbiology 142:1513-1520.
13. Ljungqvist, L., A. Worsaae, and I. Heron. 1988. Antibody responses against Mycobacterium tuberculosis in 11 strains of inberd mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB, B10 and CBA/J mice. Infect. Immun. 56:1994-1998.
14. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
15. McNeil, M. R., and P. J. Brennan. 1991. Structure, function and biogenesis of the cell envelope of mycobactcria in relation to bacterial physiology, pathogenesis and drug resistance: some thoughts and possibilities arising from recent structural information. Res. Microbiol. 142:451-463.
16. Middlebrook, G. 1952. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am. Rev. Tuberc. 65:765-767.
17. Minnikin, D. E. 1982. Lipids: complex lipids, their chemistry, biosynthesis and roles, p. 95-184. In C. Ratledge and J. S. Standford (ed.), The biology of mycobactcria, vol. 1. Academic Press, Inc., New York.
18. Ortalo-Magné, A., M. A. Dupont, A. Lemassu, A. B. Andersen, P. Gounon, and M. Daffé. 1995. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology 141:1609-1620.
19. Ortalo-Magné, A., A. Lemassu, M.-A. Lanéelle, F. Bardou, G. Silve, P. Gounon, G. Marchal, and M. Daffé. 1996. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178:456-461.
20. Quémard, A., C. Lacave, and G. Lanéelle. 1991. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob. Agents Chemother. 35:1035-1039.
21. Quémard, A., S. Mazères, A. Sut, G. Lanéelle, and C, Lacave. 1995. Certain properties of isoniazid inhibition of mycolic acid synthesis in cell-free systems of M. aurum and M. avium. Biochim. Biophys. Acta 1254:98-104.
22. Quémard, A., J. C. Sacchettini, A. Dessen, C. Vilchèze, R. Bittman, W. R. Jacobs, and J. S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
23. Romain, F., A. Laqueyrerie, P. Militzer, P. Pescher, P. Chavarot, M. Lagranderie, G. Auregan, M. Gheorghiu, and G, Marchal. 1993. Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect. Immun. 61:742-750.
24. Schaefer, W. B. 1960. Effect of isoniazid on the dehydrogenase activity of Mycobacterium tuberculosis. J. Bacteriol. 79:236-245.
25. Sweeley, C. C., R. Bentley, M. Makita, and W. W. Wells. 1963. Gas-liquid chromatography of trimethylsilyl derivatives of sugars and related substances. J. Am. Chem. Soc. 85:2497-2507.
26. Takayama, K. 1974. Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria. Ann. N. Y. Acad. Sci. 235:426-438.
27. Takayama, K., L. Wang, and H. L. David. 1972. Effect of isoniazid on the in vivo synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2:29-35.
28. Takayama, K., L. Wang, and R. Merkal. 1973. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid. Antimicrob. Agents Chemother. 4:62-65.
29. Winder, F. G. 1982. Mode of action of the antimicrobial agents and associated aspects of the molecular biology of the mycobacteria, p. 354-380. In C. Ratledge and J. S. Standford (ed.), The biology of mycobacteria, vol. 1. Academic Press, Inc., New York.
30. Winder, F. G., and P. B. Collins. 1970. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J. Gen. Microbiol. 63:41-48.
31. Winder, F. G., and S. A. Rooney. 1970. The effects of isoniazid on the carbohydrates of Mycobacterium tuberculosis BCG. Biochem. J. 177:355-368.
32. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (London) 358:591-593.
33. Zhang, Y., and D. B. Young. 1993. Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis. Trends Microbiol. 1:109-113.